Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$3.21M Buy
82,822
+61,735
+293% +$2.26M 0.03% 500
2024
Q4
$713K Buy
21,087
+3,581
+20% +$129K 0.01% 1213
2024
Q3
$716K Buy
17,506
+114
+0.7% +$4.66K 0.01% 1191
2024
Q2
$670K Buy
17,392
+795
+5% +$33.4K 0.01% 1168
2024
Q1
$712K Buy
16,597
+252
+2% +$10.4K 0.01% 1131
2023
Q4
$648K Sell
16,345
-1,486
-8% -$53.3K 0.01% 1114
2023
Q3
$646K Buy
17,831
+411
+2% +$14.6K 0.01% 1103
2023
Q2
$621K Buy
17,420
+3,722
+27% +$134K 0.01% 1141
2023
Q1
$487K Buy
13,698
+7,879
+135% +$276K 0.01% 1152
2022
Q4
$204K Buy
+5,819
New +$194K 0.01% 770
2022
Q3
Sell
-4,002
Closed -$218K 732
2022
Q2
$218K Buy
+4,002
New +$221K 0.01% 634
2021
Q3
Sell
-8,645
Closed -$430K 654
2021
Q2
$430K Buy
+8,645
New +$415K 0.02% 399
2020
Q3
Sell
-1,028
Closed -$52K 1079
2020
Q2
$52K Sell
1,028
-360
-26% -$18.5K ﹤0.01% 692
2020
Q1
$66K Sell
1,388
-90
-6% -$4.8K ﹤0.01% 527
2019
Q4
$87K Buy
+1,478
New +$82.2K 0.01% 441

Other funds holding GSK

Orion Portfolio Solutions's GSK Position: Q1 2025 in Review

Orion Portfolio Solutions increased its GSK (GSK) stake by 293% in Q1 2025, buying an estimated $2.26M and bringing the position to 82,822 shares worth $3.21M. The position accounts for 0.03% of the portfolio, ranked #500.

Orion Portfolio Solutions first reported a position in GSK in Q4 2019 and has held it in 15 quarters since. 857 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • Orion Portfolio Solutions held 82,822 shares of GSK worth $3.21M as of Q1 2025.
  • Orion Portfolio Solutions bought 61,735 GSK shares in Q1 2025, an estimated $2.26M.
  • GSK made up 0.03% of Orion Portfolio Solutions's portfolio in Q1 2025, its #500 holding.
  • Orion Portfolio Solutions first reported a position in GSK in Q4 2019 and has held it in 15 quarters since.
  • 857 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.